Incidence and risk factors of post COVID-19 syndrome: a Tunisian cohort study
- PMID: 38693500
- PMCID: PMC11064346
- DOI: 10.1186/s12879-023-08949-8
Incidence and risk factors of post COVID-19 syndrome: a Tunisian cohort study
Abstract
Background: It has become increasingly clear that SARS-CoV-2 infection can lead to persistent physical and mental health problems lasting weeks or months, requiring prolonged periods of clinical care and increasing the burden on the healthcare system. This phenomenon, known as post COVID-19 syndrome (PCS), is a relatively new condition, its incidence is still unclear and differs between studies.
Objectives: In this cohort study, we aimed to estimate the incidence of PCS and to identify its risk factors in the Tunisian population.
Methods: This is a prospective cohort study that enrolled patients diagnosed with COVID-19 from the triage unit of the University Hospital of Monastir, Tunisia. between April 2021 and June 2022. Patients were contacted by phone for a follow-up evaluation of PCS 12- weeks after the diagnosis date.
Results: A total of 1451 individuals diagnosed with COVID-19 during the study period, responded to the follow-up evaluation after 3 months. The incidence of PCS was found to be 44.03% (95% CI [41.47; 46.58]), with fatigue being the most common symptom (21.5%), followed by cognitive impairment (10.3%), including memory loss and difficulty concentrating. Multivariate analysis revealed that the main associated factors to PCS were female gender (RR = 1.54; CI95% [1.30 - 1.82]), pre-existing comorbidities (RR = 1.30; CI95% [1.10 - 1.52]), duration of acute COVID-19 illness (days) (RR = 1.02; CI95% [1.01 - 1.03]), hospitalization (RR = 1.27; CI95% [1.05 - 1.53]), number of COVID-19 episodes (RR = 1.46; CI 95% [1.28 - 1.67]) and patients having receive two or more doses of vaccine prior to COVID-19 infection (RR = 0.82; CI95% [0.70 - 0.96]).
Conclusion: Our study allowed to estimate the incidence and identify risk factors of PCS. Recognizing these factors could help to better understand the underlying mechanisms and guide interventions for prevention and management of this condition.
Keywords: Incidence; Post-acute COVID-19 syndrome; Prospective studies; Risk factors; Tunisia.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures


Similar articles
-
Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection.JAMA Netw Open. 2023 Jan 3;6(1):e2251360. doi: 10.1001/jamanetworkopen.2022.51360. JAMA Netw Open. 2023. PMID: 36652247 Free PMC article.
-
Post-COVID-19 cognitive symptoms in patients assisted by a teleassistance service: a retrospective cohort study.Front Public Health. 2024 Apr 16;12:1282067. doi: 10.3389/fpubh.2024.1282067. eCollection 2024. Front Public Health. 2024. PMID: 38689777 Free PMC article.
-
Fatigue in healthcare workers with mild COVID-19 survivors in Indonesia.Narra J. 2024 Apr;4(1):e656. doi: 10.52225/narra.v4i1.656. Epub 2024 Mar 20. Narra J. 2024. PMID: 38798861 Free PMC article.
-
Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis.BMC Med. 2022 Nov 15;20(1):444. doi: 10.1186/s12916-022-02656-y. BMC Med. 2022. PMID: 36380329 Free PMC article.
-
A review of post COVID syndrome pathophysiology, clinical presentation and management in children and young people.Paediatr Respir Rev. 2025 Mar;53:14-22. doi: 10.1016/j.prrv.2024.01.002. Epub 2024 Jan 18. Paediatr Respir Rev. 2025. PMID: 38423894 Review.
Cited by
-
Unveiling risk factors for post-COVID-19 syndrome development in people with type 2 diabetes.Front Endocrinol (Lausanne). 2024 Dec 11;15:1459171. doi: 10.3389/fendo.2024.1459171. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39722811 Free PMC article.
References
-
- Bonotti M, Zech ST. The Human, Economic, Social, and Political Costs of COVID-19. Recover Civ Dur COVID-19. 2021. p. 1–36.
-
- Tae C, Amanda KM, Ann P, Megan HM, Arun V. Long COVID: Long-Term Effects of COVID-19. 2022. Internet, cited on 26 august 2023, Available on: https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronavir....
-
- National Institute for Health and Care Excellence Guideline . OVID-19 rapid guideline: managing the long-term effects of COVID-19. London: NICE; 2020. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous